Medtronic's CEO Discusses Q3 2012 Results - Earnings Call Transcript

Medtronic (MDT)

Q3 2012 Earnings Call

February 21, 2012 8:00 am ET

Executives

Jeff Warren -

Omar S. Ishrak - Chairman and Chief Executive Officer

Gary L. Ellis - Chief Financial Officer, Principal Accounting Officer and Senior Vice President

Analysts

Matthew J. Dodds - Citigroup Inc, Research Division

Robert A. Hopkins - Bank of America Corporation

David R. Lewis - Morgan Stanley, Research Division

Michael N. Weinstein - JP Morgan Chase & Co, Research Division

Kristen M. Stewart - Deutsche Bank AG, Research Division

David H. Roman - Goldman Sachs Group Inc., Research Division

Larry Biegelsen - Wells Fargo Securities, LLC, Research Division

Adam T. Feinstein - Barclays Capital, Research Division

Sara Michelmore - Brean Murray, Carret & Co., LLC, Research Division

Joanne K. Wuensch - BMO Capital Markets U.S.

Presentation

Operator

Good morning. My name is Christie, and I will be your conference operator today. At this time, I would like to welcome everyone to the Medtronic's Third Quarter Earnings Release Conference Call. [Operator Instructions] Thank you. I would now like to hand the program over to Jeff Warren, Vice President, Investor Relations. Please go ahead.

Jeff Warren

Thank you, Christie. Good morning and welcome to Medtronic's Third Quarter Conference Call and Webcast. During the next hour, Omar Ishrak, Medtronic Chairman and Chief Executive Officer; and Gary Ellis, Medtronic Chief Financial Officer, will provide comments on the results of our fiscal year 2012 third quarter which ended January 27, 2012. After our prepared remarks, we'll be happy to take your questions.

First, a few logistical comments. Earlier this morning, we issued a press release containing our financial statements and a revenue-by-business summary. You should also note that some of the statements made during this call may be considered forward-looking statements and that actual results might differ materially from those projected in any forward-looking statement. Additional information concerning factors that could cause actual results to differ is contained in our periodic reports filed with the SEC. Therefore, we do not undertake to update any forward-looking statement. In addition, the reconciliations of any non-GAAP financial measures are available on the Investor's portion of our website at medtronic.com.

If you liked this article you might like

Medtronic Looks Vulnerable to a Bigger Decline

FDA Approves Abbott Heart Device, Stock Rises

Measure the Meaning of This Rally: Cramer's 'Mad Money' Recap (Tues 8/22/17)

The 10 Stocks America's Biggest Hedge Funds Are Dumping Like Crazy

Cramer: This Rally Isn't Without Meaning